Introduction: Despite high-dose 3,4-methylenedioxymethamphetamine (MDMA) drug alerts being distributed, no research has been conducted as to changes in use in response. This study aimed to determine if: (i) high-dose MDMA drug alerts, and (ii) varied descriptions of dose, effects and actions to reduce harm were associated with intentions to reduce the initial MDMA dose in a hypothetical scenario.

Methods: Australians who used MDMA pills/capsules in the past year completed an online survey. Respondents were randomised into alert (n = 441) or control (n = 184) conditions, with the former receiving a high-dose MDMA alert with systematically varied descriptions of dose, effects and actions to reduce harm. Multinomial logistic regressions determined the association between receipt of drug alert (and varying alert content) and hypothetical MDMA dosing.

Results: Almost half (45.4%) of those in any alert condition reported intention to not use (20.7% of control participants) and 46.7% stated they would use and reduce their initial dose (69.0% of control group). Compared to the control group, those who received an alert were significantly more likely to report intention to not use the drug, as compared to taking a smaller initial dose (adjusted relative risk ratio [aRRR] = 3.28, 95% confidence interval [CI] 2.13, 5.07) or taking the same/higher initial dose (aRRR = 2.62, 95% CI 1.31, 5.22). There was no significant association between different alert phrasing and intended behaviour.

Discussion And Conclusions: While there was no significant effect of variation in phrasing, receipt of an alert promoted intended harm reduction behaviours. Future research assessing actual behaviour and different substances (e.g., heroin, methamphetamine) is important to further understand the utility of this public health communication.

Download full-text PDF

Source
http://dx.doi.org/10.1111/dar.14037DOI Listing

Publication Analysis

Top Keywords

high-dose mdma
12
initial dose
12
alert
9
mdma
8
drug alert
8
mdma drug
8
drug alerts
8
varied descriptions
8
descriptions dose
8
dose effects
8

Similar Publications

Introduction: Despite high-dose 3,4-methylenedioxymethamphetamine (MDMA) drug alerts being distributed, no research has been conducted as to changes in use in response. This study aimed to determine if: (i) high-dose MDMA drug alerts, and (ii) varied descriptions of dose, effects and actions to reduce harm were associated with intentions to reduce the initial MDMA dose in a hypothetical scenario.

Methods: Australians who used MDMA pills/capsules in the past year completed an online survey.

View Article and Find Full Text PDF

Objective: To evaluate the comparative effectiveness and acceptability of oral monotherapy using psychedelics and escitalopram in patients with depressive symptoms, considering the potential for overestimated effectiveness due to unsuccessful blinding.

Design: Systematic review and Bayesian network meta-analysis.

Data Sources: Medline, Cochrane Central Register of Controlled Trials, Embase, PsycINFO, ClinicalTrial.

View Article and Find Full Text PDF
Article Synopsis
  • GHB (γ-hydroxybutyrate) is a powerful substance that affects the brain, similar to alcohol and ecstasy, and can lead to severe withdrawal symptoms that last longer than usually expected.
  • A male patient in his 30s, with a long history of GHB use, experienced multiple severe withdrawal episodes over 56 days, requiring extensive medical intervention, including sedation and tracheal intubation.
  • The case indicates that managing GHB withdrawal may need a slow tapering process to prevent recurring severe symptoms, suggesting that benzodiazepines and GABA-B receptor agonists are effective treatments.
View Article and Find Full Text PDF

MDMA enhances positive affective responses to social feedback.

J Psychopharmacol

March 2024

Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA.

Background: The prosocial compound ± 3,4-methylenedioxymethamphetamine (MDMA) is an amphetamine derivative that has shown promise as an adjunct to psychotherapy in the treatment of post-traumatic stress disorder. MDMA increases positive responses to social images, and it has been suggested that the ability of MDMA to positively bias social perception may underlie its therapeutic efficacy as a psychotherapy adjunct. However, the effect of the compound on affective responses to positive or negative social feedback has not been tested.

View Article and Find Full Text PDF

Psilocybin and lysergic acid diethylamide (LSD) experiences can range from very positive to highly challenging (e.g., fear, grief, and paranoia).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!